월계화 추출물의 면역억제 효능 연구

다국어 초록 (Multilingual Abstract)

The nuclear factor of activated T cells (NFAT) protein induces transcriptions of cytokine genes including IL-2 for T-cell activation. Normally activation of NFAT is important to induce immune responses but excessive NFAT activation provokes immunopathological reactions such as autoimmunity, transplant rejection, and inflammation. Thus, for the treatment of autoimmune diseases drugs repressing the activation of NFAT have been searched. In this study, immnunosuppressive effects of Rosa chinensis Jacq. extracts identified as a potent NFAT inhibitor from a natural product library were examined. NFAT reporter assay, MTS assay, real time PCR, IL-2 ELISA, MLR, and FACS (Fluorescent Activated Cell Sorting) were used to measure inhibitory immunocyte activities of Rosa chinensis Jacq. The variety of natural products have been screened and some were found to show inhibitory activities against the NFAT transcription factor. Among them, extract of Rosa chinensis Jacq. showed an strong inhibitory effect on the activation of NFAT without affecting cell viability. Levels of IL-2 transcripts as well as IL-2 protein were decreased with treatment of Rosa chinensis Jacq. extract. In addition, immunosuppressive activity of Rosa chinensis Jacq. extract was exhibited in the mixed leukocytes reaction. The increasement of CD4+CD25+ (Treg) immunocyte was also detected in the analysis using FACS after applying Rosa chinensis Jacq. extract. Immunosuppressive effects of the Rosa chinensis Jacq. extracts were clearly demonstrated in the present study. In addition, Rosa chinensis Jacq. extract also positively affected regulatory T cell induction. Further investigations in particular on purification of single substance responsible for the immunosuppressive effects from the extract and analysis on possible actions of the extract in interfering cell signaling and cytokine production will be needed.

참고문헌 (Reference)

1 오정희, "재활의학" 대학서림 309-319, 1986

2 안덕균, "완역 중약대사전 권7" 도서출판 정담 3317-3319, 1999

3 윤영석, "신장이식에서의 면역억제제" 13 (13): 66-85, 1994

4 허성범, "말초혈액 CD4+CD25- T 세포로부터 IL-4로 유도된 CD4+CD25+ 면역조절 T 세포의 획득과 특성 규명" 대한류마티스학회 12 (12): 263-277, 2005

5 유 빈, "류마티스 관절염의 약물치료" 20 (20): 559-, 1996

6 醫聖堂 編輯部, "校正中藥大辭典(上)" 醫聖堂 358-, 1994

7 國家中醫藥管理局≪中華本草≫編委會, "中華本草4券" 上海科學技術出版社 215-217, 1999

8 Macián, F., "Transcriptional Mechanisms Underlying Lymphocyte Tolerance" 109 (109): 719-731, 2002

9 Jonuleit, H., "The regulatory T cell family: distinct subsets and their interrelations" 171 (171): 6323-6327, 2003

10 Bennett, C.L., "The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3" 27 (27): 20-21, 2001

11 Mattila, P.S., "The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes" 9 (9): 4425-4433, 1990

12 Holbrook, N.J, "T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells" 81 : 1634-1638, 1984

13 Nel, A.E, "T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse" 109 : 758-770, 2002

14 Yang, T.T., "Quantification of gene expression with a secreted alkaline phosphatase reporter system" 23 : 1110-1114, 1997

15 Dambrin, C., "Pharmacodynamics of immunosuppressive drugs" 12 : 557-562, 2000

16 Sakaguchi, S., "Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease" 305 : 51-56, 2006

17 Shearer, G.M., "Mixed lymphocyte reactivity and cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes in C57BL/10 congenic and B10-A recombinant mouse strains" 141 (141): 930-934, 1975

18 Smith, K.A, "Interleukin-2" 4 : 271-276, 1992

19 Sakaguchi, S., "Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance" 182 : 18-32, 2001

20 Sakaguchi, S., "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases" 155 : 1151-1164, 1995

21 Takahashi, T., "Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4" 192 : 303-310, 2000

22 Clipstone, N.A., "Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation" 357 (357): 695-697, 1992

23 Diehn, M., "Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation" 99 : 11796-11801, 2002

24 E. Bettelli, "FoxP3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells" 5138-51143, 2005

25 Fantini, M.C., "Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7" 172 : 5149-5153, 2004

26 Chen, W., "Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3" 198 : 1875-1885, 2003

27 Hori, S, "Control of regulatory T cell development by the transcription factor Foxp3" 299 : 1057-1061, 2003

28 Shevach, E.M., "Control of T-cell activation by CD4+ CD25+suppressor T cells" 182 : 58-67, 2001

29 Shevach, E.M, "CD4+ CD25+ suppressor T cells: more questions than answers" 2 : 389-400, 2002

30 Wang, L., "An Association between Immunosenescence and CD4+CD25+Regulatory T Cells: A Systematic Review" 23 (23): 327-332, 2010